Bourre et al., 2003 - Google Patents
Synthesis, and in vitro and in vivo evaluation of a diphenylchlorin sensitizer for photodynamic therapyBourre et al., 2003
View HTML- Document ID
- 3734150542400782241
- Author
- Bourre L
- Simonneaux G
- Ferrand Y
- Thibaut S
- Lajat Y
- Patrice T
- Publication year
- Publication venue
- Journal of Photochemistry and Photobiology B: Biology
External Links
Snippet
This paper reports the synthesis of a new diphenylchlorin photosensitizer, 2, 3-dihydro-5, 15- di (3, 5-dihydroxyphenyl) porphyrin (SIM01). The photodynamic properties, cell uptake and localization of SIM01 were compared with those of structurally related meso-tetra …
- 231100000489 sensitizer 0 title abstract description 23
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bourre et al. | Synthesis, and in vitro and in vivo evaluation of a diphenylchlorin sensitizer for photodynamic therapy | |
Dichiara et al. | Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents | |
Patel et al. | Highly effective dual-function near-infrared (NIR) photosensitizer for fluorescence imaging and photodynamic therapy (PDT) of cancer | |
Juzeniene et al. | The history of PDT in Norway: Part one: Identification of basic mechanisms of general PDT | |
Roeder et al. | Photophysical properties and photodynamic activity in vivo of some tetrapyrroles | |
Sun et al. | Photodynamic Therapy with Pyropheophorbide‐a Methyl Ester in Human Lung Carcinoma Cancer Cell: Efficacy, Localization and Apoptosis¶ | |
Rück et al. | Fluorescence formation during photodynamic therapy in the nucleus of cells incubated with cationic and anionic water-soluble photosensitizers | |
Lai et al. | Special reactive oxygen species generation by a highly photostable BODIPY-based photosensitizer for selective photodynamic therapy | |
JPS625924A (en) | Novel tetrapyrrole polyamino monocarboxylic acid pharmaceutical composition | |
Luz et al. | Translating phototherapeutic indices from in vitro to in vivo photodynamic therapy with bacteriochlorins | |
Kramer-Marek et al. | Spectroscopic properties and photodynamic effects of new lipophilic porphyrin derivatives: efficacy, localisation and cell death pathways | |
EP3292129B1 (en) | Low molecular weight halogenated porphyrine carboxamide chlorin and bacteriochlorin derivatives for use in photodynamic therapy for treating cancer | |
Bonnett et al. | Photobleaching of compounds of the 5, 10, 15, 20-Tetrakis (m-hydroxyphenyl) porphyrin Series (m-THPP, m-THPC, and m-THPBC) | |
Dąbrowski et al. | Tissue uptake study and photodynamic therapy of melanoma‐bearing mice with a nontoxic, effective chlorin | |
Kessel et al. | Photosensitization with derivatives of chlorin p6 | |
Chen et al. | A photoactivatable theranostic probe for simultaneous oxidative stress-triggered multi-color cellular imaging and photodynamic therapy | |
Gierlich et al. | One‐photon and two‐photon photophysical properties of tetrafunctionalized 5, 10, 15, 20‐tetrakis (m‐hydroxyphenyl) chlorin (temoporfin) derivatives as potential two‐photon‐induced photodynamic therapy agents | |
Gao et al. | The photodynamic activities of dimethyl 131-[2-(guanidinyl) ethylamino] chlorin e6 photosensitizers in A549 tumor | |
Goswami et al. | Synthesis of tumor-avid photosensitizer− Gd (III) DTPA conjugates: impact of the number of gadolinium units in T1/T2 relaxivity, intracellular localization, and photosensitizing efficacy | |
Ferrand et al. | Hydroporphyrins as tumour photosensitizers: synthesis and photophysical studies of 2, 3-dihydro-5, 15-di (3, 5-dihydroxyphenyl) porphyrin | |
Gül et al. | BODIPY precursors and their cyclotriphosphazene derivatives: Synthesis, photochemical properties and their application in PDT | |
Grin et al. | Novel bacteriochlorophyll-based photosensitizers and their photodynamic activity | |
Chen et al. | Construction of diene-extended meso-CF3-BODIPY for spectroscopic study and photothermal exploration | |
Fraix et al. | A multi-photoresponsive molecular-hybrid for dual-modal photoinactivation of cancer cells | |
Fuse et al. | Elucidating the mode of action for thiophene-based organic D-π-A sensitizers for use in photodynamic therapy |